SCHEMBL20141182

SCHEMBL20141182

Cc1ccc(CN2CCN(c3ccccc3C#N)CC2)cc1C(=O)N1CCN(c2ccc(F)c(C)n2)CC1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.48
MTOR P42345 4/20 0.44
RPTOR Q8N122 4/20 0.44
MLST8 Q9BVC4 4/20 0.44
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 3/20 0.44
HTT P42858 2/20 0.44
TACR3 P29371 1/20 0.41
TP53 P04637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GAA P10253 1/20 0.41
CLK1 P49759 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NR2F2 P24468 1/20 0.41
DRD2 P14416 1/20 0.40
DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20140590 0.89 PARP1 (0.49) PARP1MTORRPTORMLST8KDM4E
SCHEMBL20140865 0.89 MTOR (0.48) PARP1MTORRPTORMLST8KDM4E
SCHEMBL20140044 0.88 MTOR (0.54) PARP1MTORRPTORMLST8KDM4E
SCHEMBL20140472 0.87 PARP1 (0.46) PARP1MTORRPTORMLST8KDM4E
SCHEMBL20139934 0.87 PPARG (0.47) PARP1MTORRPTORMLST8KDM4E
SCHEMBL20140585 0.85 PPARG (0.47) PARP1MTORRPTORMLST8TACR3
SCHEMBL20156887 0.85 PPARG (0.46) PARP1MTORRPTORMLST8KDM4E
SCHEMBL20156963 0.85 GBA1 (0.45) PARP1MTORRPTORMLST8
SCHEMBL20140304 0.85 GBA1 (0.44) PARP1MTORRPTORMLST8KDM4E
SCHEMBL20140693 0.84 HCRTR1 (0.49) PARP1MTORRPTORMLST8KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089433-A1 PHENYL mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
WO-2018089433-A1 PHENYL mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed